Broadly Neutralizing Antibodies 3BNC117-LS & 10-1074-LS to Prevent Relapse During ATI

NCT05079451 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

NIH

Sponsor class

Stopped Protocol Withdrawal

Conditions

HIV Infections

Interventions

DRUG: 3BNC117-LS
DRUG: 10-1074-LS

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]